The muscular dystrophy (MD) research ecosystem relies on data generated across clinical trials, natural history studies, patient registries, and real-world clinical care; however, these datasets are typically developed independently, using different instruments, format and terminologies. As a result, datasets are frequently fragmented, siloed, inconsistently structured, and described using non-standardized terminology, limiting their discoverability, interoperability, and reuse. In rare diseases such as MDs, where individual datasets are inherently small, this fragmentation constrains pooled analyses, reduces statistical power, and slows biomarker development, endpoint validation, and efficient clinical trial design.
The Rare Disease Cures Accelerator–Data and Analytics Platform (RDCA-DAP), led by the Critical Path Institute (C-Path), was established to address these challenges through a centralized, pre-competitive data sharing and integration and collaboration framework. As a neutral convener, C-Path brings together patient advocacy organizations, academic researchers, industry sponsors, regulators, and data custodians under a trusted governance model that preserves data ownership, privacy, and consent obligations. Centralizing collaboration within RDCA-DAP reduces redundant infrastructure, distributes risk and cost, and enables consensus-driven approaches to shared challenges in the MD space.
RDCA-DAP is a secure, cloud-based platform that provides controlled access to de-identified rare disease datasets and applies a responsive curation pipeline aligned with FAIR Principles . Datasets are made discoverable upon ingestion and, when prioritized for analysis, are harmonized to common data models such as OMOP and CDISC SDTM. Together, biomedical ontologies, data model harmonization and ontology-based annotation, enable semantic interoperability, supporting consistent cohort definition, synonym-aware search, and cross-dataset integration across diverse MDs data sources and study designs.
By transforming disconnected datasets into a semantically integrated resource, RDCA-DAP provides a scalable solution to data silos in muscular dystrophy. The platform enables deeper disease understanding, supports regulatory-grade evidence generation, and advances collaborative efforts to accelerate therapy development for individuals living with MDs.